一篇评论文章:肥胖和结肠直肠癌之间的关系
Lily Nguyen1, Skandan Shanmugan2
1Department of Surgery, Division of Colon and Rectal Surgery, University of California, 333 The City Blvd West, Suite 1600, Suite 1600, Irvine, CA, USA, 92868-3298.
Current diabetes reports
|December 2, 2024
概括
肥胖增加了结直肠癌 (CRC) 的风险,并使结果恶化. 虽然减肥手术显示出希望,但需要更多的研究来了解CRC患者减肥的好处.
科学领域:
- 在瘤学瘤学.
- 代谢综合征是代谢综合征的一种.
- 胃肠病学 胃肠病学
背景情况:
- 肥胖是一个日益严重的全球健康问题.
- 越来越多的证据将肥胖与各种癌症联系在一起,包括结直肠癌 (CRC).
- 了解这种关系对于患者管理和治疗策略至关重要.
研究的目的:
- 审查有关肥胖和结直肠癌的当前文献.
- 检查肥胖对CRC发展,治疗和患者结果的影响.
- 讨论风险缓解策略和知识差距.
主要方法:
- 最近研究的文献综述.
- 分析生化机制和流行病学数据.
- 对治疗结果和风险因素的评估.
主要成果:
- 肥胖与增加的CRC风险,较差的结果和更高的术后并发症率有关.
- 生物化学途径涉及炎症和肠道微生物组的改变.
- 腹腔外科手术可能会降低CRC风险;GLP-1激动剂的结果是混合的.
- 预康复是唯一证明的方法来减少肥胖患者手术后的发病率.
结论:
- 肥胖严重影响CRC的风险和结果.
- 需要进一步的研究来阐明肥胖个体中CRC的病因学和流行病学.
- 确定CRC减肥干预措施的治疗优势是一个优先事项.
更多相关视频
相关概念视频
Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
Regulation of Food Intake
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...


